Summary

For kidney cancer, TCGA will create a reference genome, against which new patients will be compared, for both clear cell and papillary cancer types. The According to the NIH, the initial objectives of TCGA for kidney cancer are, according to the NIH:

• Identify unique patterns of genomic changes that divide clear cell and papillary carcinoma tumors into subgroups.
• Identify genomic differences that distinguish tumors across gender, race, or ethnicity.
• Determine if specific patterns of genomic changes are connected to tumor recurrence after therapy.

Research and Publications

Please contact us at cancerimagingarchive@mail.nih.gov if you have any questions about these policies.

...

Imaging Source Site (ISS) Groups will be populated and governed by participants from institutions that have provided imaging data to the archive for a given cancer type. Modeled after TCGA analysis groups, these ISS groups are given the opportunity to publish a marker paper for a given cancer type per the aforementioned publication policy. It is hoped that this type per TCGA Publication Guidelines. This opportunity will generate increased participation in the building of these multi-institutional data sets that as they become an open community resource.  Current  Current TCGA-KIRC source sites include:

...

Please contact Dr. Oguz Akin (akino@mskcc.org) if you have scientific questions you would like to direct to the for TCGA-KIRC ISS or are interested in collaborating with their group.

...

The following links contain publications from the main TCGA project , as well as their posted publication guidelines.:

• TCGA Publications
• TCGA Publication Guidelines

...